UPTAKE MEDICAL CORP
Vapor ablation device for pulmonary disease treatment
- Sector
- Medtech
- Headquarters
- Tustin, CA
- Founded
- 2004
- Latest Form D
- $1.9M, Dec 2015
- Total capital
- $45.9M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $45.9M
- 5 Form D · last Dec 2015
- 131 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2014
- Rank in peer group#498 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$1.9M
- Private capital raisedForm D · SEC · 4th filing$35.1M
- Private capital raisedForm D · SEC · 3rd filing$4.9M
- Private capital raisedForm D · SEC · 2nd filing$601K
- Private capital raisedForm D · SEC · 1st filing$3.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#498 · top 45%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Robert L. BarryResearcherExecutive Officer, Director, PromoterLinked by 1 patent
- Andrew SchiffDirectorNamed in SEC Form D filings
- Carl SimpsonDirectorNamed in SEC Form D filings
- Carl King SimsonDirectorNamed in SEC Form D filings
- David King SingerDirectorNamed in SEC Form D filings
- Eric KimDirectorNamed in SEC Form D filings
Show all 17 people
- Geoff BrookeDirectorNamed in SEC Form D filings
- J. C. MacRaeExecutive OfficerNamed in SEC Form D filings
- John BrooksDirectorNamed in SEC Form D filings
- Krista MannExecutive OfficerNamed in SEC Form D filings
- Michael HoeyDirectorNamed in SEC Form D filings
- R. King NelsonExecutive Officer, DirectorNamed in SEC Form D filings
- R. King NelsonExecutive Officer, DirectorNamed in SEC Form D filings
- Robert King KuhlingDirectorNamed in SEC Form D filings
- Robert Kuhling, Jr.DirectorNamed in SEC Form D filings
- Sami King SindiDirectorNamed in SEC Form D filings
- Scott HuennekensDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- GrantedDetermining Patient-Specific Vapor Treatment and Delivery ParametersUSPTOUS 8,734,380
- PendingMethods and Apparatus for Ablating Lung Nodules with VaporUSPTOApplication 13860420
- PendingDetermining Patient-specific Vapor Treatment And Delivery ParametersUSPTOApplication PCTUS2008080688
Show all 4 patent records
- Determining Patient-Specific Vapor Treatment and Delivery ParametersMay 27, 2014 · US 8,734,380Granted
- Methods and Apparatus for Ablating Lung Nodules with VaporOct 10, 2013 · Application 13860420Pending
- Determining Patient-specific Vapor Treatment And Delivery ParametersApplication PCTUS2008080688Pending
- High Pressure And High Temperature Vapor Catheters And SystemsApplication PCTUS2007084592Pending
Related companies, and why
- ORIGEN THERAPEUTICS INC /CASimilar federal contract value in Medtech · null in contracts
- VYCOR MEDICAL INCSimilar federal contract value in Medtech · null in contracts
- Portela Soni Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Device Innovation Group, LLCSimilar federal contract value in Medtech · null in contracts
- Applied BioCode, Inc.Similar federal contract value in Medtech · null in contracts
- Bakersfield Lithotripsy, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .